Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) Enterprise Value (2016 - 2025)

STRATA Skin Sciences' Enterprise Value history spans 14 years, with the latest figure at -$7.1 million for Q3 2025.

  • For Q3 2025, Enterprise Value rose 15.72% year-over-year to -$7.1 million; the TTM value through Sep 2025 reached -$7.1 million, up 15.72%, while the annual FY2024 figure was -$8.6 million, 5.46% down from the prior year.
  • Enterprise Value for Q3 2025 was -$7.1 million at STRATA Skin Sciences, down from -$6.0 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$4.2 million in Q1 2023 and bottomed at -$17.5 million in Q1 2021.
  • The 5-year median for Enterprise Value is -$8.5 million (2023), against an average of -$9.4 million.
  • The largest annual shift saw Enterprise Value skyrocketed 61.68% in 2023 before it tumbled 56.98% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$12.6 million in 2021, then surged by 46.01% to -$6.8 million in 2022, then fell by 19.47% to -$8.1 million in 2023, then dropped by 5.46% to -$8.6 million in 2024, then increased by 17.35% to -$7.1 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Enterprise Value are -$7.1 million (Q3 2025), -$6.0 million (Q2 2025), and -$7.8 million (Q1 2025).